Hepatitis A and B Vaccine

Hepatitis A/B antigen and antibody report issued in last 3 months must be presented prior to Hepatitis A/HepatitisB/Hepatitis A&B vaccination. Extra fee for blood test will be applied if you cannot present a valid report.

Hepatitis A is a liver disease caused by the hepatitis A virus (HAV). Clinical features of hepatitis A are similar to those of other types of viral hepatitis. Typical signs and symptoms of hepatitis A include fever, malaise, loss of appetite, diarrhoea, nausea, abdominal discomfort, or jaundice (yellowing discolouration of the skin and sclera of the eyes, dark urine and pale stool). Not everyone who is infected will have all of the symptoms. Adults have signs and symptoms of illness more often than children, and the severity of disease increases in older age groups. Recovery from symptoms following infection may be slow and may take several weeks or months. Hepatitis A infection does not cause chronic liver disease and is rarely fatal, but it can cause debilitating symptoms and fulminant hepatitis (acute liver failure), which is associated with high mortality. HAV is transmitted primarily by the faecal-oral route, that is when an uninfected person contacts or ingests objects, food or water that has been contaminated with the faeces of an infected person. The virus can also be transmitted through close physical contact with an infectious person including sexual contact and not limited to anal-oral contact. Hepatitis A outbreaks among men who have sex with men (MSM) have been reported. Waterborne outbreaks, though infrequent, are usually associated with sewage-contaminated or inadequately treated water. The incubation period of hepatitis A is usually 14 – 28 days.

If hepatitis B patients do not receive proper treatment, approximately 15-40% of them may develop liver cirrhosis or liver cancer. According to local data, nearly 80% of liver cancer patients have a history of hepatitis B infection. Hepatitis B is a viral infection that affects the liver and can cause both acute and chronic liver disease. HBV is transmitted through contact with the blood or other bodily fluids of an infected person. In endemic places, most persons with chronic hepatitis B (CHB) acquired HBV infection by mother-to-child transmission. The hepatitis B vaccine is an effective way to protect against the hepatitis B virus (HBV) infection.

A total of three shots are required to produce hepatitis A and B antibodies on your own and prevent hepatitis A and B.